Image 5_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff by Chao-Chao Chen (21090215)

“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”

Table 4_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”

Table 5_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx by Chao-Chao Chen (21090215)

“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”

Supplementary file 1_The role of micro-CT in breast cancer management: a systematic review on the clinical applications of micro-CT in breast cancer and a diagnostic accuracy meta-... by Seyed Mostafa Meshkati Yazd (15198320)

“…Micro-computed tomography (micro-CT) has already exhibited clinical value, yielding high-resolution three-dimensional (3D) volumetric images. …”

Table 1_Impact of different 3D regions of interest on quantifying dynamic lumbar vertebral microstructure in ovariectomized rats—a micro-CT study.doc by Huihui Xu (778437)

“…However, whether different ROIs directly affect the results of quantitative micro-CT-based microarchitectural data is still unknown. …”

ROC curve of HPDL-MIAIHD method on 60:40 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

Loss curve of HPDL-MIAIHD method on 60:40 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

Confusion matrices of (a-b) 60:40 of TRAP/TESP and (c-d) 70:30 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

ICH recognition outcome of HPDL-MIAIHD technique on 60:40 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

Average of HPDL-MIAIHD methodology on 70:30 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

Overall flow of the HPDL-MIAIHD approach. by Naif Almakayeel (16846021)

Subjects:

outcome of HPDL-MIAIHD technique with recent methods [11–12]. by Naif Almakayeel (16846021)

Subjects:

ICH recognition outcome of HPDL-MIAIHD methodology on 60:40 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

curve of HPDL-MIAIHD methodology on 60:40 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

Details on database. by Naif Almakayeel (16846021)

Subjects:

Architecture of EfficientNet. by Naif Almakayeel (16846021)

Subjects:

outcome of HPDL-MIAIHD technique with recent methods. by Naif Almakayeel (16846021)

Subjects:

Average of HPDL-MIAIHD technique on 60:40 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

PR curve of HPDL-MIAIHD method on 60:40 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

Data Sheet 1_Changes in pancreatic levodopa uptake in patients with obesity and new-onset type 2 diabetes: an 18F-FDOPA PET-CT study.docx by Yeongkeun Kwon (3611216)

“…</p>Results<p>Pancreatic levodopa uptake increased in obese patients with insulin resistance, whereas it decreased in obese patients with new-onset type 2 diabetes [standardized uptake value (SUV) mean in participants with normal weight, 2.6 ± 0.7; SUV_mean in patients with obesity, 3.6 ± 0.1; SUV_mean in patients with obesity and new-onset type 2 diabetes, 2.6 ± 0.1, P = 0.02].…”